ZetaMAST — 2266041
Application number
2266041
Registration number
TMA1260256
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2023-06-27
Registered
2024-09-30
Registration Expiry Date
2034-09-30
Registered Owner
Zetagen Therapeutics, Inc.
841 East Fayette Street
Syracuse, NY 13210
UNITED STATES OF AMERICA
Agent
DEETH WILLIAMS WALL LLP
150 YORK STREET, SUITE 400
TORONTO
ONTARIO M5H3S5
Documents
Index headings
- ZETAMAST
- ZETA MAST
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical products for the treatment of tumour and metastatic tumour diseases; pharmaceutical preparations for the treatment of tumour and metastatic tumours and lesions; Pharmaceuticals, namely, for destroying, inhibiting or preventing the spread of uncontrolled growth of abnormal tissues, namely, tumour and metastatic tumours and lesions
Claims
- Priority Filing Date: January 04, 2023, Country or Office: UNITED STATES OF AMERICA, Application No. 97/741,225 in association with the same kind of goods
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2023-06-27 | ||
| Created | 2023-06-27 | ||
| Formalized | 2023-06-27 | ||
| Pre-Assessment Letter Sent | 2023-07-13 | Goods or Services Not Acceptable | |
| Search Recorded | 2024-06-05 | ||
| Approved | 2024-06-13 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2024-06-13 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2024-07-10 | Vol.71 Issue 3637 | |
| Registration Pending | 2024-09-30 | ||
| Registered | 2024-09-30 | 2034-09-30 |